THE SCIENCE
Brain Blend combines Semax and Selank, two synthetic peptides studied independently in research involving the central nervous system. Semax research has explored neurobiological signaling and neural function, while Selank research has examined neurochemical processes and behavioral responses.
MOLECULAR STRUCTURE
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH). Selank is a synthetic peptide related to the naturally occurring peptide tuftsin. Both have distinct amino acid sequences and molecular characteristics that influence their biological properties.
NEUROBIOLOGY & CELLULAR SIGNALING
Research involving Semax has examined pathways associated with neuronal function, neurotrophic signaling, and cellular responses in the nervous system. Studies involving Selank have explored neurochemical signaling and processes involved in central nervous system regulation.
NEUROTRANSMITTER & NEUROCHEMICAL RESEARCH
Selank has been investigated in relation to neurotransmitter systems, including pathways involving GABA, a neurotransmitter associated with inhibitory signaling in the central nervous system. Semax research has explored interactions with neurochemical signaling and mechanisms associated with neural activity.
COGNITIVE & BEHAVIORAL RESEARCH
- Research involving Semax and Selank has explored areas such as learning, memory, attention, stress-related responses, and behavior in experimental and clinical settings. The scope and strength of findings vary across research areas and study designs.
PRECLINICAL & RESEARCH CONTEXT
Research on Semax and Selank includes preclinical investigations and, for some applications, human studies. The available evidence varies by peptide, research question, and study quality. Research on the individual peptides should be distinguished from evidence specifically evaluating the combined Brain Blend formulation.